TABLE 71.
Locally acquired human West Nile neuro‐invasive disease (WNND) cases (confirmed and probable) and notification rates per 100,000 population in EU MSs and non‐MS countries, by country and year, 2018–2022.
| Country | 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National coverage a | Data format a | Confirmed cases | Total cases and rate | Total cases and rate | Total cases and rate | Total cases and rate | Total cases and rate | ||||||
| Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | ||||
| Austria | Y | C | 1 | 1 | 0.01 | 1 | 0.01 | 0 | 0 | 1 | 0.01 | 4 | 0.05 |
| Belgium | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bulgaria | Y | C | 1 | 1 | 0.01 | 0 | 0 | 1 | 0.01 | 4 | 0.06 | 13 | 0.18 |
| Croatia | Y | C | 3 | 3 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 47 | 1.1 |
| Cyprus | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 2.3 | 1 | 0.12 |
| Czechia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.01 | 3 | 0.03 |
| Denmark b | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Estonia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Finland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| France | Y | C | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | < 0.01 | 7 | 0.01 |
| Germany | Y | C | 7 | 7 | 0.01 | 2 | < 0.01 | 7 | 0.01 | 3 | < 0.01 | 0 | 0 |
| Greece | Y | C | 135 | 184 | 1.7 | 38 | 0.36 | 116 | 1.1 | 140 | 1.3 | 241 | 2.2 |
| Hungary | Y | C | 8 | 11 | 0.11 | 7 | 0.07 | 1 | 0.01 | 23 | 0.24 | 152 | 1.6 |
| Ireland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Italy | Y | C | 330 | 330 | 0.56 | 35 | 0.06 | 46 | 0.08 | 24 | 0.04 | 243 | 0.40 |
| Latvia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Lithuania | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Luxembourg | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Malta | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netherlands | Y | C | 0 | 0 | 0 | 0 | 0 | 6 | 0.03 | 0 | 0 | 0 | 0 |
| Poland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Portugal | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Romania | Y | C | 46 | 47 | 0.25 | 7 | 0.04 | 6 | 0.03 | 65 | 0.33 | 277 | 1.4 |
| Slovakia | Y | C | 0 | 1 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovenia | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0.19 |
| Spain | Y | C | 3 | 3 | 0.01 | 6 | 0.01 | 72 | 0.15 | 0 | 0 | 0 | 0 |
| Sweden | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EU Total 27 | – | – | 536 | 591 | 0.13 | 96 | 0.02 | 255 | 0.06 | 282 | 0.06 | 992 | 0.23 |
| United Kingdom c | – | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| EU Total | – | – | 536 | 591 | 0.13 | 96 | 0.02 | 255 | 0.06 | 282 | 0.06 | 992 | 0.20 |
| Iceland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norway | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liechtenstein | Y | C | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Switzerland d | Y | C | 0 | – | – | – | – | ||||||
Abbreviations: WNND, West Nile Neuro‐invasive Disease; –, Data not reported.
Y, yes; N, no; A, aggregated data; C, case‐based data.
Not notifiable, no surveillance system exists.
Cases reported by the United Kingdom for the period 2018–2019 were also taken into account for this estimation (EU‐28). Data for the United Kingdom were collected for the 2018–2019 period, since it was still an EU MS at that time. However, on 1 February 2020, it became a third country.
Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for the years 2018–2020.